Concepedia

Noelia Fandos

NF

Statistics

Publications

11

Citations

942

H-Index

11

Active since

2013

Affiliations

SOM Biotech (Spain)(Current)

Australian e-Health Research Centre

Florey Institute of Neuroscience and Mental Health

The University of Melbourne

Amsterdam University Medical Centers

Noelia Fandos is an author at SOM Biotech (Spain) specializing in amyloid beta peptides, alzheimer disease, and neurodegeneration.

Publications per year

2013–2023

11

Publications

11

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

Inge M.W. Verberk, Els O. Misdorp, Jannet Koelewijn et al. · Alzheimer s & Dementia · 2021 · 243 citations · Full text

, , +17

Total Aβ <sub>42</sub> /Aβ <sub>40</sub> ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis

James D. Doecke, Virginia Pérez‐Grijalba, Noelia Fandos et al. · Neurology · 2020 · 194 citations · Full text

, , +15

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

Noelia Fandos, Virginia Pérez‐Grijalba, Pedro Pesini et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 188 citations · Full text

, , +17

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition

Shannon L. Risacher, Noelia Fandos, Judith Romero et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2019 · 103 citations · Full text

, , +17

The global Alzheimer's Association round robin study on plasma amyloid β methods

Josef Pannee, Leslie M. Shaw, Magdalena Korecka et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2021 · 45 citations · Full text

, , +17

1–5 of 11